Staskin, David Frankel, Jeffrey Varano, Susann Shortino, Denise Jankowich, Rachael Mudd, Paul N Jr
Published in
The Journal of urology
We assessed efficacy, safety and tolerability of vibegron, a novel, potent, highly selective β3-adrenoceptor agonist, administered 12 weeks at 75 mg once daily to patients with overactive bladder in an international phase III trial with placebo and active control. Adult patients with overactive bladder with 8.0 or more micturitions per day were ran...
Laguna, M Pilar
Published in
The Journal of urology
Chan, Katherine
Published in
The Journal of urology
Gessner, Kathryn H Smith, Angela B
Published in
The Journal of urology
Chen, Yufan B Hochstedler, Baylie Pham, Thythy T Acevedo-Alvarez, Marian Mueller, Elizabeth R Wolfe, Alan J
Published in
The Journal of urology
We examined the urethral microbiota, determined if it differs from the bladder urinary microbiota, and assessed if its composition differs based on patient demographic factors and presence of lower urinary tract symptoms. Patients presenting to our urogynecology clinic were enrolled in the study. Demographic information and responses to the Pelvic ...
Chandrasekar, Thenappan
Published in
The Journal of urology
Michel, Martin C
Published in
The Journal of urology
Canning, Douglas A
Published in
The Journal of urology
Vertosick, Emily A Häggström, Christel Sjoberg, Daniel D Hallmans, Göran Johansson, Robert Vickers, Andrew J Stattin, Pär Lilja, Hans
Published in
The Journal of urology
A prespecified statistical model based on 4 kallikrein markers in blood, commercially available as the 4Kscore®, has been shown to accurately detect high grade (greater than Grade Group 2) prostate cancer in men with moderately elevated prostate specific antigen. We assessed whether the model predicted prostate cancer metastasis or death in men not...
Maranchie, Jodi K
Published in
The Journal of urology
